These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8560094)

  • 21. Occult intracellular calcium pools: relevance to neutrophil oxidant production.
    Weisdorf DJ; Thayer MS
    J Lab Clin Med; 1989 Sep; 114(3):260-5. PubMed ID: 2549140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Huang YJ; Chen IS; Tseng CP; Day YJ; Lin YC; Liao CH
    Biochem Pharmacol; 2008 Feb; 75(3):688-97. PubMed ID: 17988652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The blockade of formyl peptide-induced respiratory burst by 2',5'-dihydroxy-2-furfurylchalcone involves phospholipase D signaling in neutrophils.
    Wang JP; Chang LC; Hsu MF; Lin CN
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):166-74. PubMed ID: 12928764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide.
    Mitsuyama T; Hidaka K; Furuno T; Hara N
    Int Arch Allergy Immunol; 1997 Oct; 114(2):111-5. PubMed ID: 9338603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
    Samuelsson J; Hansson A; Rosendahl K; Palmblad J
    J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
    Macickova T; Pecivova J; Nosal R; Lojek A; Pekarova M; Cupanikova D
    Neuro Endocrinol Lett; 2008 Oct; 29(5):790-3. PubMed ID: 18987595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone.
    Colton CA; Chernyshev ON
    Neurochem Int; 1996 Jul; 29(1):43-53. PubMed ID: 8808788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate.
    Ervens J; Schultz G; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):370-6. PubMed ID: 1649410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antiasthma drugs on superoxide anion generation from human polymorphonuclear leukocytes or hypoxanthine-xanthine oxidase system.
    Kato M; Morikawa A; Kimura H; Shimizu T; Nakano M; Kuroume T
    Int Arch Allergy Appl Immunol; 1991; 96(2):128-33. PubMed ID: 1663088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjects.
    Liu S; Ngo DT; Stewart S; Horowitz JD; Chirkov YY
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):739-43. PubMed ID: 25115801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages.
    Takei K; Tokuyama K; Kato M; Morikawa A
    Pharmacology; 1998 Jul; 57(1):1-7. PubMed ID: 9670206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P; Woodward DF; Armstrong RA
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotactic peptide receptor-cytoskeletal interactions and functional correlations in differentiated HL-60 cells and human polymorphonuclear leukocytes.
    Rao KM; Currie MS; Cohen HJ; Weinberg JB
    J Cell Physiol; 1989 Oct; 141(1):119-25. PubMed ID: 2550479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
    Fletcher MP
    J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma.
    Miyatake H; Suzuki K; Taki F; Takagi K; Satake T
    Arzneimittelforschung; 1991 May; 41(5):552-6. PubMed ID: 1654910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes.
    Thiel M; Bardenheuer H; Pöch G; Madel C; Peter K
    Biochem Biophys Res Commun; 1991 Oct; 180(1):53-8. PubMed ID: 1656978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug modulation of superoxide anion production from human neutrophils.
    Fantozzi R; Brunelleschi S; Cremonesi P; Pagella PG; Ciani D; Sportoletti GC
    Int J Tissue React; 1985; 7(2):149-52. PubMed ID: 2863232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.